Alamar Biosciences, Inc. ALMR
28.05 USD +1.14 (+4.26%)
At closeNov 6, 2026, 4:01 PM EST
28.05 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
26.35 Day range 28.15
18.85 52-week range 39.61
- YTD
- +27.50%
- 1 year
- +27.50%
Analyst view
Consensus: buy
Buy
Price target (mean) 36.20 +29.1% upside
Now 28.05
- Target (low)
- 32.00
- Target (mean)
- 36.20
- Target (high)
- 45.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.25738 | -0.28 – -0.23475 | 0.00 | 0.0% | 33.35M | 0.0% | 2 |
| Next quarter | -0.23 | -0.23 – -0.23 | 0.00 | 0.0% | 36.33M | 0.0% | 1 |
| Current year | -1.22 | -1.30 – -1.06 | 0.00 | 0.0% | 122.37M | 0.0% | 3 |
| Next year | -0.12 | -0.12 – -0.12 | -1.22 | +90.1% | 168.23M | +37.5% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 11, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| May 12, 2026 | TD Cowen | Initiated | — | Buy |
| May 12, 2026 | JP Morgan | Initiated | — | Overweight |
| May 12, 2026 | Stifel | Initiated | — | Buy |